EXANE DERIVATIVES - BIONTECH SE ownership

BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of BIONTECH SE
ValueSharesWeighting
Q2 2022$119,112,000
-0.8%
799
+13.5%
0.07%
+100.0%
Q1 2022$120,068,000
-21.9%
704
+18.1%
0.03%
-8.1%
Q4 2021$153,643,000
+5.6%
596
+11.8%
0.04%
+5.7%
Q3 2021$145,499,000
+101.2%
533
+53.2%
0.04%
+118.8%
Q2 2021$72,327,000
-32.3%
348
-64.4%
0.02%
-48.4%
Q1 2021$106,783,000
+33.9%
9780.0%0.03%
+34.8%
Q4 2020$79,723,0009780.02%
Other shareholders
BIONTECH SE shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 148,674$16,151,94319.26%
Quinn Opportunity Partners LLC 659,383$71,635,3699.22%
Systrade AG 50,000$5,432,0004.70%
Crocodile Capital Partners GmbH 29,586$3,214,2233.03%
ALTRINSIC GLOBAL ADVISORS LLC 700,421$76,093,7372.94%
Temasek Holdings (Private) Ltd 4,518,080$490,844,2112.92%
PARUS FINANCE (UK) Ltd 25,662$2,787,9201.74%
FLOSSBACH VON STORCH AG 3,513,215$381,675,6781.68%
AtonRa Partners 4,707$511,3681.07%
Baader Bank Aktiengesellschaft 135,093$14,617,4560.99%
View complete list of BIONTECH SE shareholders